Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Paweł Krawczyk

Promoter Polymorphisms of TOP2A and ERCC1 Genes as Predictive Factors for Chemotherapy in Non‐small Cell Lung Cancer Patients

Cancer Medicine

English

Sensitive Methods for Detection of the S768R Substitution in Exon 18 of the DDR2 Gene in Patients With Central Nervous System Metastases of Non-Small Cell Lung Cancer

English

Evaluation of miR-506 and miR-4316 Expression in Early and Non-Invasive Diagnosis of Colorectal Cancer

International Journal of Colorectal Disease

Gastroenterology

2017

English

The Impact of ACE Gene Polymorphism on the Incidence and Phenotype of Sarcoidosis in Rural and Urban Settings

Archives of Medical Science

Medicine

2016

English

Impact of I/D Polymorphism of ACE Gene on Risk of Development and Course of Chronic Obstructive Pulmonary Disease

Archives of Medical Science

Medicine

2016

English

The Application of Real-Time PCR Technique to Detect Rare Cell Clones With Primary T790M Substitution of EGFR Gene in Metastases of Non-Small Cell Lung Cancer to Central Nervous System in Chemotherapy Naive Patients

Pathology and Oncology Research

English

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma

Pathology and Oncology Research

English

Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients With Advanced NSCLC Treated With Cisplatin and Gemcitabine

Pathology and Oncology Research

English

MicroRNAs Aid the Assessment of Programmed Death Ligand�1 Expression in Patients With Non‑small Cell Lung Cancer

English

Letter to the Editor Concerning First-Line Therapy With Afatinib – An Irreversible EGFR TKI and Overall Survival of NSCLC Patients With EGFR Gene Mutations

Wspolczesna Onkologia

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Paweł Krawczyk

Promoter Polymorphisms of TOP2A and ERCC1 Genes as Predictive Factors for Chemotherapy in Non‐small Cell Lung Cancer Patients

Sensitive Methods for Detection of the S768R Substitution in Exon 18 of the DDR2 Gene in Patients With Central Nervous System Metastases of Non-Small Cell Lung Cancer

Evaluation of miR-506 and miR-4316 Expression in Early and Non-Invasive Diagnosis of Colorectal Cancer

The Impact of ACE Gene Polymorphism on the Incidence and Phenotype of Sarcoidosis in Rural and Urban Settings

Impact of I/D Polymorphism of ACE Gene on Risk of Development and Course of Chronic Obstructive Pulmonary Disease

The Application of Real-Time PCR Technique to Detect Rare Cell Clones With Primary T790M Substitution of EGFR Gene in Metastases of Non-Small Cell Lung Cancer to Central Nervous System in Chemotherapy Naive Patients

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma

Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients With Advanced NSCLC Treated With Cisplatin and Gemcitabine

MicroRNAs Aid the Assessment of Programmed Death Ligand�1 Expression in Patients With Non‑small Cell Lung Cancer

Letter to the Editor Concerning First-Line Therapy With Afatinib – An Irreversible EGFR TKI and Overall Survival of NSCLC Patients With EGFR Gene Mutations